Clinical Trial Update: Adebrelimab and Chemoradiotherapy in High-risk LANPC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy for high-risk locally advanced nasopharyngeal carcinoma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | Phase 2 | Status: RECRUITING